GlassScriptPhysician profile
Catherine M Bonk
NPI 1952355455
$559.77
in general payments reported to CMS, 2019-2025
17 companies · $38.69 in 2025
The $38.69 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.79 · 2020: $68.33 · 2022: $139 · 2023: $151 · 2024: $71.45 · 2025: $38.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $261.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $78.38 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $75.32 | 2023-2024 | Myfembree |
| Exeltis, USA INC. | $54.20 | 2019-2022 | |
| Sage Therapeutics, LLC | $40.12 | 2022 | |
| Pfizer INC. | $36.40 | 2019-2022 | |
| Hologic Sales and Service, LLC | $36.07 | 2023-2025 | Thinprep 2000 Processor, Omni Hysteroscope, Myosure Tissue Removal Device |
| Organon LLC | $31.95 | 2024 | |
| Merck Sharp & Dohme LLC | $31.66 | 2022-2023 | Gardasil 9 |
| Becton, Dickinson and Company | $28.00 | 2022 | |
| Allergan, INC. | $26.96 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $25.87 | 2023 | |
| Therapeuticsmd, INC. | $18.26 | 2019 | |
| Coopersurgical, INC. | $17.70 | 2025 | Paragard T 380a |
| Medicem INC. | $17.03 | 2023 | |
| Astellas Pharma US INC | $15.61 | 2023 | Veozah |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15.21 | 2022 | |
| Roche Diagnostics Corporation | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Bonk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.